Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Diedrich

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Chemical Communications (Cambridge, England)|January 27, 2016
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitorsD Diedrich, A Hamacher, C G W Gertzen, et al.
Nature Communications|September 14, 2022
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemiaXujie Zhao, Ping Wang, Jonathan D Diedrich, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Leukemia|March 14, 2021
Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Leukemia|July 3, 2024
Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Nature Communications|May 1, 2024
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatmentKashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatmentKashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Blood Advances|June 7, 2022
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemiaDaniel C Ferguson, J Robert McCorkle, Kelly R Barnett, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|January 27, 2016
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitorsD Diedrich, A Hamacher, C G W Gertzen, et al.
Nature Communications|September 14, 2022
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemiaXujie Zhao, Ping Wang, Jonathan D Diedrich, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Leukemia|March 14, 2021
Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Leukemia|July 3, 2024
Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Nature Communications|May 1, 2024
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatmentKashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatmentKashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Blood Advances|June 7, 2022
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemiaDaniel C Ferguson, J Robert McCorkle, Kelly R Barnett, et al.
Pageof 3